Similarly, knocking down galectin-1 expression in 4T1 cells led to a diminished proportion of CD4+CD25+Foxp3+ Treg cells within the tumor microenvironment as well as peripheral immune organs. The gene discussed is FOXP3; the disease is neoplasm.